Skip to main content
logo
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
10.53
+0.01 (0.10%)
At close: Aug 5, 2026, 4:00 PM EDT
10.39
-0.14 (-1.33%)
After-hours: Aug 5, 2026, 7:50 PM EDT

Zevra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
622509448272159305
Market Cap Growth
1.20%13.81%64.53%71.60%-48.00%499.98%
Enterprise Value
402.41381.61438.41248.0889.82194.14
Last Close Price
10.538.968.346.554.598.71
PE Ratio
11.506.64----
Forward PE
18.5119.15102.50102.50102.5024.17
PS Ratio
4.574.7818.969.9115.1610.64
PB Ratio
2.873.2911.284.392.112.40
P/TBV Ratio
3.003.58--2.112.04
P/FCF Ratio
51.90----29.50
P/OCF Ratio
48.76----29.21
EV/Sales Ratio
2.963.5818.579.038.596.78
EV/EBITDA Ratio
4.57----24.31
EV/EBIT Ratio
4.65----25.12
EV/FCF Ratio
33.55----18.78
Debt / Equity Ratio
0.000.411.510.700.180.01
Debt / EBITDA Ratio
0.02----0.20
Debt / FCF Ratio
0.05----0.15
Net Debt / Equity Ratio
-1.01-0.83-0.23-0.39-0.92-0.87
Net Debt / EBITDA Ratio
-2.502.170.110.491.65-13.87
Net Debt / FCF Ratio
-6.7552.530.130.713.65-10.71
Asset Turnover
0.460.460.130.190.080.40
Inventory Turnover
1.498.897.53---
Quick Ratio
5.025.462.351.157.5826.92
Current Ratio
5.175.682.531.187.7227.20
Return on Equity (ROE)
-0.29%85.66%-207.75%-67.27%-41.11%-28.18%
Return on Assets (ROA)
-302.93%-28.28%-41.18%-34.49%-34.88%10.68%
Return on Invested Capital (ROIC)
-45477.62%-228.37%-211.01%-224.36%-382.41%76.85%
Return on Capital Employed (ROCE)
34.64%-32.32%-71.71%-49.13%-36.64%11.68%
Earnings Yield
8.45%15.07%----
FCF Yield
1.93%----3.39%
Buyback Yield / Dilution
-13.45%-23.81%-30.46%-2.79%-15.87%-647.71%
Total Shareholder Return
-13.45%-23.81%-30.46%-2.79%-15.87%-647.71%
SEC Filings: 10-K · 10-Q